Other reported effects Beyond GI symptoms, clinical trials noted several other effects worth monitoring: Increased heart rate: A small, dose-dependent increase in resting heart rate was observed, consistent with what occurs with other GLP-1 agonists
The Centers for Disease Control and Prevention (CDC) recommends setting a weekly weight loss target of reducing your daily calorie intake by 500 calories eatinga balanced diet of whole grains, lean proteins, low fat dairy, fruits, and vegetables limiting added sugars, sodium, saturated and trans fats, and alcohol getting at least 150 minutesweekly of moderate intensity aerobic exercise strength training for at least 2 days weekly sleeping for 7 to 9 hourseach night regularly checking in with a doctor, personal trainer, or registered dietitian Learn more about how to lose weight sustainably
Always check the products instructions and talk to a healthcare provider
Related Articles Tesamorelin: Clinical Data for Visceral Fat Reduction Phase III trial data showing 15-18% visceral fat reduction and the FDA approval rationale for Egrifta
If you do not have enough red blood cells, your body will not function properly due to a lack of oxygen in your organs and tissue